...
首页> 外文期刊>Clinical Pharmacology: Advances and Applications >Vitamin B12 deficiency presenting as pseudo-thrombotic microangiopathy: a case report and literature review
【24h】

Vitamin B12 deficiency presenting as pseudo-thrombotic microangiopathy: a case report and literature review

机译:维生素B12缺乏表现为假性血栓性微血管病:一例病例报告并文献复习

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Pseudo-thrombotic microangiopathy (pseudo-TMA) is a recognized, yet uncommon, clinical presentation of vitamin B12 deficiency. Patients with pseudo-TMA present with microangiopathic hemolytic anemia (MAHA), thrombocytopenia and schistocytes. They are often misdiagnosed as thrombotic thrombocytopenia purpura (TTP) and receive unnecessary therapy. Here, we report a case of a 60-year-old male who presented with thrombocytopenia and normocytic normochromic anemia. Anemia work-up was remarkable for severe B12 deficiency (60?pg/mL) and a positive non-immune hemolysis panel. Peripheral smear was reviewed and showed anisocytes, poikilocytes, schistocytes and hypersegmented neutrophils. Vitamin B12 replacement (1000?mcg IM daily) was started, ADAMTS13 activity was sent and daily plasmapheresis was initiated. Over the next 3?days, the patient’s hemoglobin and platelets were stable and the hemolysis panel showed gradual improvement. On day 4, ADAMTS13 activity results came back normal at 61%. Accordingly, plasmapheresis was discontinued, parenteral B12 replacement was continued and that resulted in gradual improvement and eventually cessation of hemolysis and normalization of hemoglobin and platelets. In this patient, parietal cell autoantibodies were positive and so the diagnosis of pernicious anemia was made. Patients with severe vitamin B12 deficiency may present with features mimicking TTP such as MAHA, thrombocytopenia and schistocytosis. An early and accurate diagnosis of pseudo-TMA has a critical clinical impact with respect to administering the correct treatment with vitamin B12 replacement and avoiding, or shortening the duration of, unnecessary therapy with plasmapheresis.
机译:伪血栓性微血管病(pseudo-TMA)是公认的但不常见的维生素B12缺乏症的临床表现。伪TMA患者表现为微血管性溶血性贫血(MAHA),血小板减少症和血细胞。他们经常被误诊为血栓性血小板减少性紫癜(TTP),并接受不必要的治疗。在这里,我们报告一例60岁男性,患有血小板减少症和正常血红细胞性贫血性贫血。严重的B12缺乏症(<60?pg / mL)和非免疫溶血试验阳性的贫血检查非常显着。复查外周涂片,显示出肛门细胞,脊髓炎细胞,血吸虫细胞和高节段的中性粒细胞。开始更换维生素B12(每天1000?mcg IM),发送ADAMTS13活性并开始每日血浆清除。在接下来的3天中,患者的血红蛋白和血小板稳定,溶血组逐渐改善。在第4天,ADAMTS13活动结果恢复正常,为61%。因此,中止血浆置换,继续进行肠胃外B12置换,导致逐渐改善并最终停止溶血以及血红蛋白和血小板正常化。在该患者中,壁细胞自身抗体呈阳性,因此诊断为恶性贫血。严重缺乏维生素B12的患者可能表现出模仿TTP的特征,例如MAHA,血小板减少症和血吸虫病。伪TMA的早期准确诊断对于使用维生素B12替代物进行正确的治疗以及避免或缩短不必要的血浆置换疗法的治疗具有至关重要的临床影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号